You might have alpha-gal syndrome and have no idea — and neither might your doctor. In this episode, Andrea and Ashley go deeper on the numbers (up to 450,000 Americans may be living with AGS, and it's not even a reportable condition), who's most at risk, why the lone star tick's expanding range means this is no longer just a Southern problem, and why a positive antibody test doesn't automatically mean you have the disease. They also get into the 2023 CDC survey that found nearly half of healthcare providers had never even heard of alpha-gal — which explains a lot about why so many patients end up bouncing between IBS diagnoses, anxiety labels, and "idiopathic" everything before anyone connects the dots.

Plus: the controversial philosophical paper that argued deliberately giving people alpha-gal could be a form of "moral bioenhancement" — and why that take falls apart the moment you talk to an actual patient.

📬 Reach us:Andrea – ⁠[email protected]⁠ | ⁠www.rmhealthpartners.com⁠Ashley – ⁠[email protected]⁠ | ⁠www.karvefitness.co